Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Stable efficacy and safety after switching from intravenous to subcutaneous tocilizumab in a cohort of 200 patients in real life conditions.
Joint Bone Spine. 2022 Jul;89(4):105347. doi: 10.1016/j.jbspin.2022.105347. Epub 2022 Jan 20.
Joint Bone Spine. 2022.
PMID: 35066185
No abstract available.
Drug maintenance of a second tumor necrosis factor alpha inhibitor in spondyloarthritis patients: A real-life multicenter study.
Krajewski F, Andras L, Pereira-Gillion C, Goupille P, Salliot C.
Krajewski F, et al. Among authors: pereira gillion c.
Joint Bone Spine. 2019 Nov;86(6):761-767. doi: 10.1016/j.jbspin.2019.07.003. Epub 2019 Jul 18.
Joint Bone Spine. 2019.
PMID: 31326602
Item in Clipboard
Application of Recommendations Regarding the Use of Subcutaneous Tumor Necrosis Factor Inhibitors in Spondyloarthritis by Rheumatologists in Daily Practice.
Pereira-Gillion C, Marot M, Griffoul-Espitalier I, Andras L, Goupille P, Salliot C.
Pereira-Gillion C, et al.
J Rheumatol. 2018 Apr;45(4):491-497. doi: 10.3899/jrheum.170587. Epub 2018 Feb 1.
J Rheumatol. 2018.
PMID: 29419472
Item in Clipboard
Cite
Cite